MDMA’s Leahey Sees Reasons for Concern and Optimism from Medtech Talk

MDMA’s Leahey Sees Reasons for Concern and Optimism

25 minutes Posted Apr 29, 2015 at 4:00 am.

0:00

25:42

Share at current time

Show notes

Mark Leahey of the MDMA explains how a move against patent troll could cut the legs out from Medtech entrepreneurs and VCs dependent upon IP protection.

← See all 207 episodes of Medtech Talk